The Journal of Steroid Biochemistry and Molecular Biology

Author Index
pp. VII-VII(1)

Subject index
pp. V-VI

List of contents
pp. III-IV(1)

Proceedings of the 14th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology - ''Recent Advances in Steroid Biochemistry & Molecular Biology'' (Quebec, Canada, 24-27 June 2000)
pp. 1-1(1)
Author: Pasqualini J.R.

New insights into receptor ligand binding domains from a novel assembly assay
pp. 3-7(5)
Authors: Pissios P.; Tzameli I.; Moore D.D.

Compartmentalization of regulatory proteins in the cell nucleus
pp. 9-21(13)
Authors: Hendzel M.J.; Kruhlak M.J.; MacLean N.A.B.; Boisvert F.-M.; Lever M.A.; Bazett-Jones D.P.

Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation
pp. 23-30(8)
Authors: Claessens F.; Verrijdt G.; Schoenmakers E.; Haelens A.; Peeters B.; Verhoeven G.; Rombauts W.

Selective modulation of thyroid hormone receptor action
pp. 31-42(12)
Authors: Baxter J.D.; Dillmann W.H.; West B.L.; Huber R.; Furlow J.D.; Fletterick R.J.; Webb P.; Apriletti J.W.; Scanlan T.S.

Studies of the effects of 1,25-dihydroxyvitamin D on skeletal and calcium homeostasis and on inhibition of tumor cell growth
pp. 43-47(5)
Authors: Goltzman D.; White J.; Kremer R.

Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein
pp. 49-59(11)
Authors: Norman A.W.; Ishizuka S.; Okamura W.H.

Control of the estrogen-like actions of the tamoxifen-estrogen receptor complex by the surface amino acid at position 351
pp. 61-70(10)
Authors: Levenson A.S.; MacGregor Schafer J.I.; Bentrem D.J.; Pease K.M.; Jordan V.C.

Molecular and pharmacological aspects of antiestrogen resistance
pp. 71-84(14)
Authors: Clarke R.; Skaar T.C.; Bouker K.B.; Davis N.; Lee Y.R.; Welch J.N.; Leonessa F.

Paradoxical interactions among estrogen receptors, estrogens and SERMS: mutual annihilation and synergy
pp. 85-93(9)
Authors: Kaye A.M.; Spatz M.; Waisman A.; Sasson S.; Tamir S.; Vaya J.; Somjen D.

The selective estrogen enzyme modulator (SEEM) in breast cancer
pp. 95-104(10)
Authors: Chetrite G.S.; Pasqualini J.R.

Hormonal regulation of tumor suppressor proteins in breast cancer cells
pp. 105-117(13)
Authors: Moudgil V.K.; Dinda S.; Khattree N.; Jhanwar S.; Alban P.; Hurd C.

Estrogen regulated proteases and antiproteases in ovarian and breast cancer cells
pp. 119-124(6)
Authors: Rochefort H.; Chalbos D.; Cunat S.; Lucas A.; Platet N.; Garcia M.

Vitamin D and prostate cancer
pp. 125-134(10)
Authors: Tuohimaa P.; Lyakhovich A.; Aksenov N.; Pennanen P.; Syvala H.; Lou Y.R.; Ahonen M.; Hasan T.; Pasanen P.; Blauer M.; Manninen T.; Miettinen S.; Vilja P.; Ylikomi T.

The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer
pp. 135-142(8)
Authors: Avila D.M.; Zoppi S.; McPhaul M.J.

Analysis and characteristics of multiple types of human 17-hydroxysteroid dehydrogenase
pp. 143-151(9)
Author: Luu-The V.

Expression of the 11-hydroxysteroid dehydrogenase type II enzyme in breast tumors and modulation of activity and cell growth in PMC42 cells
pp. 153-159(7)
Authors: Koyama K.; Myles K.; Smith R.; Krozowski Z.

Resistance to multiple steroids in two sisters
pp. 161-166(6)
Authors: New M.I.; Nimkarn S.; Brandon D.D.; Cunningham-Rundles S.; Wilson R.C.; Newfield R.S.; Vandermeulen J.; Barron N.; Russo C.; Loriaux D.L.; O'Malley B.

Interaction of thyroid hormone and steroidogenic acute regulatory (StAR) protein in the regulation of murine Leydig cell steroidogenesis
pp. 167-177(11)
Authors: Manna P.R.; Roy P.; Clark B.J.; Stocco D.M.; Huhtaniemi I.T.

Recent advances in the clinical application of aromatase inhibitors
pp. 179-186(8)
Authors: Harper-Wynne C.; Dowsett M.

Regulation of steroidogenic enzymes and a novel testicular RNA helicase
pp. 187-197(11)
Authors: Dufau M.L.; Tsai-Morris C.-H.; Tang P.-Z.; Khanum A.

Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors
pp. 199-202(4)
Authors: Bhatnagar A.S.; Brodie A.M.H.; Long B.J.; Evans D.B.; Miller W.R.

MHC class II expression and antigen presentation by human endometrial cells
pp. 203-211(9)
Authors: Wallace P.K.; Yeaman G.R.; Johnson K.; Collins J.E.; Guyre P.M.; Wira C.R.

Multiple signal transduction pathways mediate interleukin-4-induced 3-hydroxysteroid dehydrogenase/5-4 isomerase in normal and tumoral target tissues
pp. 213-225(13)
Authors: Gingras S.; Cote S.; Simard J.

Alzheimer's disease and estrogen
pp. 227-230(4)
Authors: Honjo H.; Kikuchi N.; Hosoda T.; Kariya K.; Kinoshita Y.; Iwasa K.; Ohkubo T.; Tanaka K.; Tamura T.; Urabe M.; Kawata M.

Tibolone: a steroid with a tissue-specific mode of action
pp. 231-238(8)
Author: Kloosterboer H.J.